Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Jason Rhodes joins Atlas Venture investing team
Jason Rhodes, who recently exited his position as president of Epizyme ($EPZM), is making the hop to Atlas Venture, the well-known early-stage VC group based in Cambridge, MA. Rhodes joined Epizyme in 2010 through its $196 million IPO and before that had served as VP of business development at Alnylam ($ALNY). Release
Biotech > NewLink Genetics ($NLNK) has appointed Jack Henneman as executive vice president and chief financial officer. Release > Bio-Rad Laboratories ($BIO) has appointed John Goetz as chief operating officer. Release > Dr. Jan Brinkman and Alan Hoberman have joined Boston Therapeutics' ($BTHE) board of directors. Release > Susheel Surpal has stepped down as chief financial officer of Ipsen ($IPN). Release > Relmada Therapeutics ($RLMD) has appointed Julie Chen as its director of finance and operations. Release > Mast Therapeutics ($MSTX) has appointed Dr. Edwin Parsley as its chief medical officer and senior vice president. Release > Brian McLellan was promoted to president of Astellas Pharma Technologies in the Americas region. Release > Neurocrine Biosciences ($NBIX) has named Malcolm Lloyd-Smith as chief regulatory officer. Release > Agile Therapeutics ($AGRX) has appointed Dr. James Tursi to its board of directors. Release > CytoDyn ($CYDY) has appointed Carl Dockery to its board of directors. Release > IntelGenx ($IGXT) has appointed Horst Zerbe as president and chief executive officer. Release > BBB Therapeutics (formerly to-BBB) brought on Dr. Ferdinand Massari and Pericles Calias as chief medical officer and chief scientific officer, respectively. Release> Leidos Biomedical Research named James Bahel its VP of business development. Release > Protalix Biotherapeutics appointed Moshe Manor as its president and CEO. Release > David Ricketts joined LINK as the company's new CEO. Release > NeoGenomics ($NEO) brought on Robert Shovlin as its chief operating officer. Release > Agilis named Dr. James Darnell of Rockefeller University as a member of its scientific advisory board. Release > Cambridge Major Laboratories appointed Marcel Schreuder Goedheijt as its general manager. Release > Susan Boynton joined Arrowhead ($ARWR) as vice president of global regulatory affairs. Release > Verona Pharma appointed Biresh Roy as CFO and a member of the board. Release > Generex named Lakshmi Kotra as part of its Buccal Insulin Enhancement Project. Release > Dr. Hal Barron, president of R&D at Google's ($GOOG) Calico, has been appointed to the board of Juno Therapeutics. Release > Stephen Aselage will take over as interim CEO, to replace Martin Shkreli, founder and CEO of Retrophin. Release Pharma > Zynerba Pharmaceuticals has appointed Armando Anido as chief executive officer and chairman of the board. Release > Conatus Pharmaceuticals ($CNAT) has appointed David Hagerty as executive vice president of clinical development. Release > Horizon Pharma's ($HZNP) commercial chief Todd Smith resigned from the position. Release > Cerulean Pharma ($CERU) appointed Alejandra Carvajal as VP and general counsel. Release > Inovio Pharmaceuticals ($INO) appointed Jennifer Laux as its vice president of commercial development. Release > Accelovance brought on Dr. Joseph Purvis, former VP of oncology at Pfizer ($PFE), to the same position. Release > Ritter Pharmaceuticals named Michael Step its CEO. Release > Torbjörn Bjerke left Karolinska Development and the company appointed Klaus Wilgenbus as acting CEO. Release | Story > Nimbus Discovery appointed Donald Nicholson as its CEO. Release > Shameze Rampertab, vice president of finance and chief financial officer, has resigned from IntelliPharmaCeutics ($IPCI). Release Vaccines > Dr. Jon Andrus joined the Sabin Vaccine Institute as its executive vice president. Release |
||||
